DE60023816D1 - Verwendung von Lycopin in Zusammensetzungen zur Behandlung von Hautalterungs-Erscheinungen - Google Patents

Verwendung von Lycopin in Zusammensetzungen zur Behandlung von Hautalterungs-Erscheinungen

Info

Publication number
DE60023816D1
DE60023816D1 DE60023816T DE60023816T DE60023816D1 DE 60023816 D1 DE60023816 D1 DE 60023816D1 DE 60023816 T DE60023816 T DE 60023816T DE 60023816 T DE60023816 T DE 60023816T DE 60023816 D1 DE60023816 D1 DE 60023816D1
Authority
DE
Germany
Prior art keywords
lycopene
compositions
treatment
skin aging
aging phenomena
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE60023816T
Other languages
English (en)
Other versions
DE60023816T2 (de
Inventor
Raluca Lorant
Lionel Breton
Christel Liviero
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26212291&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60023816(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR9912507A external-priority patent/FR2799368A1/fr
Application filed by LOreal SA filed Critical LOreal SA
Application granted granted Critical
Publication of DE60023816D1 publication Critical patent/DE60023816D1/de
Publication of DE60023816T2 publication Critical patent/DE60023816T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)
DE60023816T 1999-10-07 2000-09-07 Verwendung von Lycopin in Zusammensetzungen zur Behandlung von Hautalterungserscheinungen Revoked DE60023816T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9912507 1999-10-07
FR9912507A FR2799368A1 (fr) 1999-10-07 1999-10-07 Utilisation du lycopene dans des compositions destinees a traiter les signes cutanes du vieillissement
FR0003849A FR2799370B1 (fr) 1999-10-07 2000-03-27 Utilisation du lycopene dans des compositions destinees a traiter les signes cutanes du vieillissement
FR0003849 2000-03-27

Publications (2)

Publication Number Publication Date
DE60023816D1 true DE60023816D1 (de) 2005-12-15
DE60023816T2 DE60023816T2 (de) 2006-08-03

Family

ID=26212291

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60023816T Revoked DE60023816T2 (de) 1999-10-07 2000-09-07 Verwendung von Lycopin in Zusammensetzungen zur Behandlung von Hautalterungserscheinungen

Country Status (5)

Country Link
US (1) US6623769B1 (de)
EP (1) EP1090628B1 (de)
DE (1) DE60023816T2 (de)
ES (1) ES2253192T3 (de)
FR (1) FR2799370B1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2811561B1 (fr) * 2000-07-13 2003-03-21 Oreal Composition, notamment cosmetique, renfermant la dhea et/ou un precurseur ou derive chimique ou biologique de celle-ci, et un inhibiteur de metalloproteinase
FR2815859B1 (fr) * 2000-10-26 2003-02-28 Oreal Utilisation de l'association d'au moins un carotenoide a activite provitaminique a et d'au moins un carotenoide sans activite provitaminique a pour traiter les signes du vieillissement
FR2815863B1 (fr) * 2000-10-26 2003-02-28 Oreal Composition comprenant l'association d'au moins un extrait d'au moins un vegetal du genre rosmarinus et d'au moins un carotenoide
FR2826266B1 (fr) 2001-06-26 2005-02-25 Oreal Composition cosmetique ou dermatologique comprenant une association entre un compose de la famille des n-acylaminoamides et au moins un inhibiteur de metalloproteinases matricielles
FR2829388B1 (fr) * 2001-09-11 2005-09-02 Oreal Utilisation d'au moins un carotenoide dans une composition cosmetique
US7354956B2 (en) * 2002-04-12 2008-04-08 L'oreal Composition containing a sapogenin and use thereof
AU2003294778A1 (en) * 2002-12-06 2004-06-30 Dsm Ip Assets B.V. Novel use of lycopene
JP5150102B2 (ja) * 2004-02-10 2013-02-20 アクゾ ノーベル サーフェス ケミストリー エルエルシー 炎症の治療のための方法および組成物
DK2233127T3 (da) 2004-03-17 2020-08-24 Stada Arzneimittel Ag Anvendelse af antioxidanter til fremstilling af en farmaceutisk eller kosmetisk sammensætning for at beskytte huden mod skader som følge af infrarød stråling
US20060039898A1 (en) * 2004-07-27 2006-02-23 Sivak Hannah N Method of skin care and/or treatment using rice (Oryza sativa) hemoglobin or other hexacoordinated, non-symbiotic plant hemoglobins
US9579298B2 (en) 2004-12-02 2017-02-28 Piotr Chomczynski Antioxidant dietary supplement compositions and methods for maintaining healthy skin
US20070122509A1 (en) * 2004-12-02 2007-05-31 Molecular Research Center, Inc. Antioxidant dietary supplement compositions and methods for maintaining healthy skin
WO2007112996A2 (en) * 2006-03-31 2007-10-11 Dsm Ip Assets B.V. Novel use of compounds and combinations of compunds for improving the physical appearance
EP1958611A1 (de) * 2006-12-20 2008-08-20 DSMIP Assets B.V. Orale Zusammensetzung mit EGCG und Lycopin
US20090028895A1 (en) * 2007-07-27 2009-01-29 Smith Walter P Methods and compositions for reducing facial lines and wrinkles
US20090162306A1 (en) * 2007-12-21 2009-06-25 Conopco, Inc., D/B/A Unilever Topical composition comprising coloring antioxidants
EP2130833A1 (de) * 2008-06-05 2009-12-09 DSM IP Assets B.V. Verfahren zur Herstellung von Zeacarotinen
FR2939040B1 (fr) * 2008-12-03 2013-08-09 Laboratoires Inneov Snc Association de lycopene, polyphenol et vitamines pour le soin des matieres keratiniques
US7993663B2 (en) * 2008-12-29 2011-08-09 Avon Products, Inc. Cosmetic use of 1-aroyl-N-(2-oxo-3-piperidinyl)-2-piperazine carboxamides and related compounds
US7994175B2 (en) * 2008-12-29 2011-08-09 Avon Products, Inc Cosmetic use of 1-aroyl-N-(2-oxo-3-piperidinyl)-2-piperazine carboxamides and related compounds
US8429236B2 (en) * 2009-04-08 2013-04-23 Research In Motion Limited Transmission of status updates responsive to status of recipient application
FR2948876B1 (fr) * 2009-08-07 2011-11-04 Oreal Association d'un rayonnement lumineux et d'un agent de nature peptidique augmentant l'expression d'un substrat de la cytochrome c oxydase pour ameliorer notamment l'apparence de la peau et/ou du cheveu
US8318215B1 (en) 2010-04-21 2012-11-27 Miriam Ryngler-Lewensztain Composition and method of preparing a tomato-based topical formulation for enhanced healing of burns, ultraviolet and radiation erythema
FR3031677B1 (fr) * 2015-01-16 2019-06-07 L'oreal Composition cosmetique pour administration par voie topique pour renforcer la barriere cutanee.
CN104643088A (zh) * 2015-03-13 2015-05-27 宁波高新区苗姑养生科技有限公司 一种小麦胚芽油营养胶囊
US9669006B2 (en) 2015-07-28 2017-06-06 U.S. Nutraceuticals, LLC Composition and method to treat and alleviate symptoms of hot flashes in a female subject

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5290605A (en) * 1989-06-29 1994-03-01 Niva Shapira Sun-exposure nutritional supporting composition
JPH08506574A (ja) * 1993-02-11 1996-07-16 バイヤースドルフ・アクチエンゲゼルシヤフト 耐水性化粧品的または皮膚科学的光保護配合物
US5648377A (en) * 1993-12-21 1997-07-15 Indena S.P.A. Formulations containing carotenoids an procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals
IT1265312B1 (it) * 1993-12-21 1996-10-31 Indena Spa Formulazioni contenenti carotenoidi e procarotenoidi associati a polifenoli nella prevenzione dei danni da abnorme produzione di
US5925348A (en) * 1996-02-23 1999-07-20 Medical Doctor's Research Institute, Inc. Methods utilizing compositions containing sacred lotus (methyltransferase) to treat aging skin
FR2749758B1 (fr) * 1996-06-12 1998-08-07 Oenobiol Sa Lab Composition a activite bronzante et photoprotectrice et ses applications esthetiques
US5895652A (en) * 1996-07-29 1999-04-20 Longevity Institute International Method of metabolic adjuvanation and cellular repair
FR2769837B1 (fr) * 1997-10-17 2000-02-25 Bio Sphere 99 Lab Composition pour dietetique ou cosmetique a base d'extraits vegetaux
JPH11246396A (ja) * 1998-02-27 1999-09-14 Shiseido Co Ltd 免疫賦活剤
US5972993A (en) * 1998-03-20 1999-10-26 Avon Products, Inc. Composition and method for treating rosacea and sensitive skin with free radical scavengers

Also Published As

Publication number Publication date
DE60023816T2 (de) 2006-08-03
US6623769B1 (en) 2003-09-23
FR2799370A1 (fr) 2001-04-13
EP1090628A1 (de) 2001-04-11
ES2253192T3 (es) 2006-06-01
FR2799370B1 (fr) 2005-08-19
EP1090628B1 (de) 2005-11-09

Similar Documents

Publication Publication Date Title
DE60023816D1 (de) Verwendung von Lycopin in Zusammensetzungen zur Behandlung von Hautalterungs-Erscheinungen
DE69941566D1 (de) N-acetylhomotaurinate zur verwendung in der behandlung von hyperkinesie
ATE271038T1 (de) 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen
DE50009504D1 (de) Verwendung von retigabin zur behandlung von neuropathischen schmerzen
ATE417602T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE60222671D1 (de) Thienopyrimidinedione und deren verwendung in der behandlung von autoimmunerkrankungen
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
ATE300597T1 (de) Behandlung von geweben
ATE357440T1 (de) Benzodiazepin-substituierte piperdine zur verwendung in der behandlung von cardiovaskulären erkrankungen
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
DE60137929D1 (de) Verwendung von lanthan bei der behandlung von knochenerkrankungen
DE60325770D1 (de) Verwendung von rimexolon zur behandlung von augentrockenheit
DE60328517D1 (de) Neue verwendung von lycopin zur behandlung von erkrankungen im zusammenhang mit androgenwirkung
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60123238D1 (de) Zusammensetzungen zur behandlung von autoimmunkrankheiten
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
DE69941497D1 (de) Schäumende Zusammensetzung zur Haarreinigung und Haarbehandlung
DE60136477D1 (de) Retinoide zur behandlung von emphysem
DE60130661D1 (de) Verwendung der 13-cis retinsäure zur behandlung von emphysemen
DE60027429D1 (de) Dihydrobenzodiazepinen und deren verwendung zur behandlung von dyslipidämien
DE60206289D1 (de) Verwendung von bibn4096 in kombination mit anderen migränemitteln zur behandlung von migräne
DE69931487D1 (de) Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation
DE69939723D1 (de) Verwendung von Intereferon Gamma zur Behandlung von Herzhypertrophie
DE60001255D1 (de) Zusammensetzung zur Behandlung von Polyesterfaser
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation